[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@FWCWeather HereForTheFreeDonut
HereForTheFreeDonut posts on X about target, $uber, ceo, linkedin the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +72%
- X Month XXXXX -XX%
- X Months XXXXX +595%
- X Year XXXXX +220%
Mentions: X #
- X Week X -XX%
- X Month XX -XXXX%
- X Months XX +2,500%
- X Year XX +200%
Followers: XXX #
- X Week XXX +2.30%
- X Month XXX +3.60%
- X Months XXX +4.90%
- X Year XXX +2.80%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence stocks XXXX% technology brands XXXX% social networks XXXX%
Social topic influence target 15.38%, $uber 7.69%, ceo 7.69%, linkedin 7.69%, $stro 7.69%, $cccc #7, $mgx 7.69%, $vera #19, $snti XXXX%
Top accounts mentioned or mentioned by @seedy19tron @biotechiq @amaymd @adamfeuerstein @biotechnerd1 @andreagtc @biostocks @pharmdca @martinshkreli @billackman @uber @dkhos @ubercom @grok @dough @semodough @rnaianalyst @ddz1928
Top assets mentioned Uber Technologies, Inc. (UBER) Vera Therapeutics, Inc. Class A Common Stock (VERA)
Top Social Posts
Top posts by engagements in the last XX hours
"@BillAckman @Uber @dkhos Blast them with emails Executive Emails Dara Khosrowshahi (CEO): khosrowshahid@uber.com Troy Stevenson (Global Head of Customer Operations): stevensont@uber.com (or TroyS@uber.com on LinkedIn) Tomasz Krawczyk (Senior Director Community Operations): krawczykt@uber.com"
X Link 2025-12-06T15:43Z XXX followers, XXX engagements
"Biotech LONG's should really check out the following companies. A great day today: $STRO: +20% $CCCC: +14% $MGX: +14% $VERA: +13% @_Biotech_iQ @dough @A_May_MD @adamfeuerstein @seedy19tron @Biotechnerd1"
X Link 2025-12-03T21:17Z XXX followers, XXX engagements
"$SNTI: 12/9/25-Leerink Partners initiated coverage with a Outperform rating & a $XXXX price target. Positive Phase X clinical data for SENTI-202 presented at ASH showed a XX% ORR and XX% complete remission rate in relapsed/refractory acute myeloid leukemia. @A_May_MD @semodough"
X Link 2025-12-09T16:31Z XXX followers, XXX engagements
"@RNAiAnalyst 12/12: Wedbush raises price target on Wave Life Sciences adds to Best Ideas List Wedbush analyst Yun Zhong added Outperform-rated Wave Life Sciences to the firm's Best Ideas List and raised the price target on the stock to $XX from $20"
X Link 2025-12-12T11:58Z XXX followers, 1915 engagements